Olink to report third quarter 2022 financial results on November 10, 2022
Rhea-AI Summary
Olink Holding AB (Nasdaq: OLK) will announce its financial results for Q3 2022 on November 10, 2022, before the market opens. A conference call with company management will follow at 8:00 am ET, providing insights into the financial performance and strategic direction of the company. Interested investors can register online for the call, and a live webcast will also be available on Olink's website. The webcast will be archived for 90 days.
Positive
- Scheduled conference call may provide insights into future growth and business strategy.
Negative
- None.
News Market Reaction – OLK
In the trading session that priced this news, OLK gained 8.43%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UPPSALA, Sweden, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the third quarter of 2022 before the market open on Thursday, November 10, 2022. Company management will host a conference call to discuss these results at 8:00 am ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live webcast of the conference call will be available in the “Events” section of the Company's website at https://investors.olink.com/investor-relations. The webcast will be archived and available for replay for at least 90 days after the event.
About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.
Investor Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com
Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com
